KLRS
Kalaris Therapeutics
KLRS
KLRS
89 hedge funds and large institutions have $156M invested in Kalaris Therapeutics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 34 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $192M → $156M (-$36.5M)
21% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 34
Holders
89
Holding in Top 10
–
Calls
$303K
Puts
$119K
Top Buyers
| 1 | +$4.96M | |
| 2 | +$2.26M | |
| 3 | +$1.27M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$687K |
| 5 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
+$186K |
Top Sellers
| 1 | -$565K | |
| 2 | -$349K | |
| 3 | -$343K | |
| 4 |
HF
HRT Financial
New York
|
-$246K |
| 5 |
Goldman Sachs
New York
|
-$215K |